Dr. Thiel on Protecting Patients and Providers From COVID-19

Video

David D. Thiel, MD, chair, discusses the measures that are being taken to protect patients and providers from the coronavirus disease 2019 (COVID-19).

David D. Thiel, MD, chair, Department of Urology, Mayo Clinic, discusses the measures that are being taken to protect patients and providers from the coronavirus disease 2019 (COVID-19).

It is important to protect all providers from COVID-19 exposure, particularly anesthesiologists who perform aerosolizing procedures such as intubation, says Thiel. Moreover, by separating COVID-19–positive patients from COVID-19–negative patients in the hospital, health care systems can reduce the risk of patient exposure to the virus.

Testing is a critical component of ensuring that COVID-19–positive patients can be distanced from COVID-19–negative patients. At Mayo Clinic, every patient who is scheduled for surgery receives a nasal swab to ensure that they don’t have the virus, says Thiel. These measures are particularly important for patients with cancer who are already immunocompromised but need to come into the clinic for treatment. Telehealth visits have helped reduce the volume of patients who come into the cancer center, but it is not appropriate for everyone.

Despite containment efforts, the virus is not likely to disappear, meaning that communities will have to learn to modify their behaviors to reduce the risk of further spread, concludes Thiel.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS